Nike
NKE
$44.65
+3.28%
Nike, Inc. is the world's largest athletic footwear and apparel brand, operating in the consumer cyclical sector with a focus on performance and lifestyle categories. The company is a dominant market leader with a globally recognized portfolio that includes its core Nike brand, the premium Jordan line, and Converse, leveraging a vast distribution network of owned stores, franchised locations, and e-commerce. The current investor narrative is dominated by a severe business downturn, with intense scrutiny on declining sales, collapsing profitability, and heightened competition in key markets like China, positioning the stock as a high-risk turnaround story rather than a growth investment.…
NKE
Nike
$44.65
Related headlines
Investment Opinion: Should I buy NKE Today?
Rating & Thesis: Hold. Nike is a high-risk, speculative turnaround story rather than a clear buy; investors should wait for concrete evidence of operational stabilization before committing new capital. The severe lack of analyst coverage (only 2 analysts) contributes to uncertainty and inefficient price discovery.
Supporting Evidence: The primary valuation metric, a forward P/E of 23.9x, is not compelling for a company with 0.09% revenue growth. Profitability is in steep decline, with Q3 net margin down 246 basis points YoY. While free cash flow generation remains solid at $2.48 billion TTM, the trend is negative. The stock's 46% discount to its 52-week high reflects these profound challenges, not an obvious margin of safety.
Risks & Conditions: The two biggest risks are continued revenue stagnation and further gross margin erosion below 40%. This Hold rating would upgrade to a Buy if the company demonstrates a return to mid-single-digit revenue growth and stabilizes gross margins above 41% for two consecutive quarters. It would downgrade to a Sell if revenue turns negative or if the stock breaks below its 52-week low of $41.35 on deteriorating fundamentals. The stock is currently fairly valued to slightly overvalued relative to its sharply decelerating growth profile.
Sign up to view all
NKE 12-Month Price Forecast
The AI assessment is neutral with medium confidence. While Nike's brand and balance sheet prevent a full bearish call, the severe and ongoing deterioration in core fundamentals—growth and margins—makes a bullish stance unjustified. The stock is in a 'show me' state. The stance would upgrade to bullish only upon clear, consecutive quarterly evidence of revenue re-acceleration and margin stabilization. It would downgrade to bearish if the stock breaks key technical support at $41.35 on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Nike's 12-month outlook, with a consensus price target around $58.05 and implied upside of +30.0% versus the current price.
Average Target
$58.05
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$36 - $58
Analyst target range
Insufficient analyst coverage data is available to form a robust consensus view; the provided data indicates only 2 analysts, which is minimal for a company of Nike's size and stature. This limited coverage can lead to higher volatility and less efficient price discovery, as the stock may be more influenced by macroeconomic sentiment and retail investor flows than by deep institutional research. The available data shows an estimated EPS average of $4.25 for an unspecified period, but without a consensus price target or recommendation breakdown, it is impossible to gauge analyst sentiment or calculate implied upside/downside from the current price.
Bulls vs Bears: NKE Investment Factors
The evidence currently favors the bear case, as the fundamental deterioration in sales and margins is severe, tangible, and ongoing, outweighing the technical and valuation arguments for a bottom. The most critical tension in the investment debate is whether Nike's powerful brand equity and solid balance sheet can provide a foundation for a successful operational turnaround before competitive pressures and margin erosion cause permanent damage to its market position. The resolution of this tension hinges on the company demonstrating a return to sustainable revenue growth and margin stabilization in upcoming quarters.
Bullish
- Deeply Oversold Technicals: The stock is down 30.5% over the past year and 33.8% over six months, trading near its 52-week low of $41.35. This severe decline has pushed the stock into oversold territory, historically a potential entry point for value investors, with a 1-month gain of 1.3% hinting at possible stabilization.
- Solid Balance Sheet: Nike maintains a strong financial foundation with a current ratio of 2.21 and a manageable debt-to-equity ratio of 0.83. This provides the company with the liquidity and flexibility to navigate its current downturn without a solvency crisis.
- Attractive Dividend Yield: The stock currently offers a dividend yield of 2.56%, which is elevated due to the share price collapse. This provides income support for patient investors while they wait for a potential turnaround.
- Valuation Compression: The trailing P/E of 27.95x, while not cheap, is significantly below its historical high of 44.21x. The forward P/E of 23.93x suggests the market is pricing in some earnings recovery, offering a lower entry multiple than in recent years.
Bearish
- Severe Revenue & Profit Collapse: Q3 FY2026 revenue growth was essentially flat at 0.09% YoY, a sharp deceleration from prior quarters. More critically, net income plunged to $520 million with a net margin of 4.61%, down from 7.07% a year ago, indicating collapsing profitability.
- Persistent Gross Margin Pressure: Gross margin contracted to 40.16% in Q3 FY2026 from 41.49% a year prior, reflecting intense promotional activity and cost inflation. This erosion directly impacts the bottom line and signals a loss of pricing power.
- Extreme Underperformance vs. Market: Nike's relative strength versus the S&P 500 is -57.55% over one year, indicating severe and persistent institutional selling. The stock's beta of 1.124 means it is falling faster than the market during downturns.
- Intense Competitive & Sector Headwinds: Recent news highlights successful competitors like Deckers Outdoor (Hoka) and On Holdings, while peers like Lululemon struggle with weak guidance. This indicates Nike's challenges are part of a broader, difficult sector environment.
NKE Technical Analysis
The stock is in a pronounced and sustained downtrend, evidenced by a 1-year price change of -30.51% and a 6-month decline of -33.77%. As of the latest close at $43.62, the price is trading near the bottom of its 52-week range, approximately 46% above the 52-week low of $41.35 but a stark 46% below the 52-week high of $80.17, indicating the stock is deeply oversold and may represent a value opportunity, though it remains a 'falling knife' with significant fundamental headwinds. Recent momentum shows a slight 1-month gain of 1.30%, which diverges from the severe longer-term downtrend, suggesting potential for a temporary technical bounce or consolidation; however, this is juxtaposed against a severe 3-month loss of -23.49%, and the stock's relative strength versus the S&P 500 is deeply negative at -57.55% over one year, highlighting persistent underperformance. Key technical support is clearly defined at the 52-week low of $41.35, while resistance sits at the 52-week high of $80.17; a sustained breakdown below $41.35 would signal a new leg down, whereas any recovery would face immense overhead supply. The stock's beta of 1.124 indicates it is approximately 12% more volatile than the broader market, which is a critical consideration for risk management given its current distressed state.
Beta
1.12
1.12x market volatility
Max Drawdown
-47.1%
Largest decline past year
52-Week Range
$41-$80
Price range past year
Annual Return
-27.9%
Cumulative gain past year
| Period | NKE Return | S&P 500 |
|---|---|---|
| 1m | +1.2% | -0.1% |
| 3m | -19.8% | +9.0% |
| 6m | -34.1% | +7.0% |
| 1y | -27.9% | +22.9% |
| ytd | -29.4% | +8.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
NKE Fundamental Analysis
Revenue growth has stalled and turned negative, with the most recent Q3 FY2026 revenue of $11.28 billion representing a mere 0.09% year-over-year increase; this follows a sequential decline from Q2's $12.43 billion, indicating a troubling deceleration and potential contraction in demand. The company remains profitable but margins are under severe pressure, with Q3 net income of $520 million and a net margin of 4.61%, a sharp drop from the 7.07% net margin in the year-ago Q3; the gross margin of 40.16% in Q3 has also compressed from 41.49% a year prior, reflecting promotional activity and cost inflation. The balance sheet remains solid with a strong current ratio of 2.21 and a debt-to-equity ratio of 0.83, indicating manageable leverage; however, cash flow generation has weakened, with trailing twelve-month free cash flow of $2.48 billion, and the return on equity of 24.36%, while still healthy, is likely under pressure from declining earnings.
Quarterly Revenue
$11.3B
2026-02
Revenue YoY Growth
+0.00%
YoY Comparison
Gross Margin
+0.40%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is NKE Overvalued?
Given Nike's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE is 27.95x, while the forward PE is 23.93x; the forward multiple being lower suggests the market is anticipating some earnings recovery, though the gap is not wide, indicating tempered expectations. Compared to sector averages, data is not available in the provided inputs for a direct industry PE comparison; however, the stock's own historical context is telling. The current trailing PE of 27.95x is below the historical high-water marks seen in recent years (e.g., 44.21x in Q3 FY2026 per historical ratios data) but is still elevated relative to periods of stronger performance, suggesting the market is pricing in a recovery that has yet to materialize, leaving the stock in a valuation purgatory between deep value and growth premium.
PE
27.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 24x~106x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Nike faces acute risks from its collapsing profitability and stalled growth. The Q3 net margin of 4.61% represents a 35% decline year-over-year, and revenue growth of 0.09% signals demand weakness. While free cash flow remains positive at $2.48 billion TTM, the trend is concerning, and the company's high return on equity of 24.36% is under direct threat from these earnings declines. Dependence on a brand-led recovery to justify its still-elevated forward P/E of 23.9x is a significant financial risk.
Market & Competitive Risks: External threats are severe. The stock's valuation, while compressed, is not deeply cheap, leaving it vulnerable to further multiple compression if growth fails to re-accelerate. Competition from focused brands like Hoka (Deckers) and On Holdings, which are gaining market share with strong growth narratives, poses a direct disruption risk. The stock's beta of 1.124 indicates it is 12% more volatile than the market, amplifying downside during sector-wide sell-offs, as evidenced by recent negative apparel sector news.
Worst-Case Scenario: The worst-case scenario involves a failure of the turnaround strategy, leading to consecutive quarters of revenue declines and further margin compression, triggering a loss of investor confidence akin to a 'value trap.' This could be exacerbated by a recession impacting consumer discretionary spending. In this scenario, the stock could re-test and break its 52-week low of $41.35, approaching the levels implied by its maximum drawdown of -47.15%. From the current price of $43.62, this represents a realistic downside risk of approximately -5% to -10%, with further declines possible if fundamentals worsen significantly.
FAQ
The key risks are, in order of severity: 1) Operational: Continued revenue stagnation and further gross margin compression below 40%, as seen in the latest quarter. 2) Competitive: Sustained market share loss to innovative rivals like Hoka and On Holdings. 3) Financial: A failure to stabilize profitability, leading to earnings downgrades that could compress the still-elevated P/E multiple further. 4) Market: The stock's high beta of 1.124 means it is likely to fall more than the market during broad downturns, as evidenced by its -57.55% relative strength over the past year.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $45 and $55 as the company struggles through a flattish growth period. The Bull Case (20% probability) targets $60-$70 on a successful turnaround. The Bear Case (25% probability) warns of a drop to $35-$41 if the downturn deepens. The Base Case is most likely, predicated on the assumption that revenue growth remains near zero and margins stabilize under pressure, leading to range-bound trading.
NKE is fairly valued to slightly overvalued relative to its current fundamentals. The forward P/E of 23.9x is not cheap for a company with stagnant growth. While it trades at a 46% discount to its 52-week high, this reflects severely worsened business conditions, not an obvious bargain. The valuation implies the market is still pricing in a successful recovery. Compared to faster-growing competitors, Nike's multiple looks stretched, suggesting the stock is not undervalued on a growth-adjusted basis.
NKE is not a good buy for most investors at this moment. It is a high-risk, speculative turnaround bet. While the stock is down over 30% in a year and offers a 2.56% dividend yield, the fundamental picture is deteriorating with nearly 0% revenue growth and collapsing margins. The forward P/E of 23.9x does not offer a compelling margin of safety. It could become a good buy for patient, risk-tolerant investors only after the company demonstrates concrete signs of operational recovery in upcoming quarterly reports.
NKE is unsuitable for short-term trading due to its high volatility (beta 1.124) and lack of near-term positive catalysts. It is only suitable for long-term investors with a minimum 3-5 year horizon who are willing to endure significant volatility while betting on a multi-year brand and operational turnaround. The dividend provides a small income cushion for holders. Given the profound business challenges, this is a long-term, high-conviction, high-patience investment, not a tactical trade.